Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Director's Interest

15 Oct 2010 16:32

RNS Number : 5056U
Pressure Technologies PLC
15 October 2010
 



 

Pressure Technologies PLC

 

("Pressure Technologies" or the "Company")

 

Director's Interest

 

Pressure Technologies was informed on 8 October 2010 by Brewin Dolphin Limited ("BDL") that as of 7 October 2010 it held an indirect interest in 119,005 ordinary shares of the Company representing 1.05% of the issued ordinary share capital and voting rights of the Company. The indirect interests are in 49,984 ordinary shares held by Brewin Nominees Limited and 69,021 ordinary shares held by Giltspur Nominees Limited. Prior to the notification above, BDL had an interest in 1,130,471 ordinary shares of Pressure Technologies, representing 9.97% of the issued ordinary share capital and voting rights of the Company.

 

Of the previous interest of BDL referred to above, 1,000,040 ordinary shares, representing 8.82% of the issued ordinary share capital and voting rights of the Company, were held and continue to be held on behalf of John Hayward, the Chief Executive Officer of Pressure Technologies. The change of BDL's interest has arisen because certain shareholdings (including John Hayward's shareholding) are now held on an advisory basis rather than a discretionary basis by BDL. For the sake of clarity, John Hayward's beneficial interest in the share capital of the Company, being 1,000,040 ordinary shares representing 8.82% of the issued share capital of the Company, remains unchanged by this event.

 

 

For further information, please contact:

 

Pressure Technologies plc

John Hayward, Chief Executive

James Lister, Group Finance Director

 

Tel: 0114 242 7500

www.pressuretechnologies.co.uk

 

Fairfax IS PLC

Ewan Leggat/Simon Bennett

 

Tel: 0207 598 5368 

Rawlings Financial PR Limited

Catriona Valentine

 

Tel: 01653 618 016

www.rawlingsfinancial.co.uk

 

 

Company description:

 

Pressure Technologies is the holding company for Chesterfield Special Cylinders Limited ("CSC"). CSC designs, manufactures and offers retesting and refurbishment services for a range of speciality high-pressure, seamless steel gas cylinders for global energy and defence markets. The business has been conducted under the "Chesterfield" brand which is a long established name in the cylinders and specialised pressure vessel market.

 

Chesterfield BioGas ("CBG"), an operating division of Pressure Technologies, formed in November 2008 following the signing of a co-operation agreement with Greenlane Biogas Limited, the world leader in biogas upgrading from raw biogas to vehicle quality fuel, gives Pressure Technologies exclusive rights to market Greenlane equipment in the UK and Eire. Chesterfield BioGas will provide turnkey solutions for the cleaning, storage and dispensing of biomethane, produced from waste water treatment and anaerobic digestion of organic waste.

 

Al-Met Limited ("Al-Met"), which was acquired by the Group in February 2010, is a niche manufacturer of specialised, precision engineered valve wear parts used in the oil and gas industries, based in Pontyclun, near Cardiff. Al-Met's products are used in high-pressure choke and flow control valves, designed to regulate flow volumes in extremely demanding applications in the subsea and surface oil and gas industries. The business, established in 1985, has developed a leading edge capability in precision machining carbides and superalloy matrix materials. The ability to combine high alloy steels with tungsten carbide inserts and specialised coatings gives Al-Met its niche position with its customers, global wellhead and subsea equipment OEMs.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASESFDAEFFF
Date   Source Headline
7th Oct 20097:00 amRNSPre-close Trading Update
1st Oct 20093:19 pmRNSDirector/PDMR Shareholding
28th Sep 20094:42 pmRNSDirector/PDMR Shareholding
27th Aug 20093:40 pmRNSGrant of Share Options
5th Aug 200911:50 amRNSHolding(s) in Company
4th Aug 20092:47 pmRNSHolding(s) in Company
4th Aug 20091:55 pmRNSDirector/PDMR Shareholding
3rd Aug 20093:16 pmRNSHolding(s) in Company
3rd Aug 20093:09 pmRNSDirector/PDMR Shareholding
10th Jun 20099:40 amRNSHolding(s) in Company
8th Jun 20095:14 pmRNSDirector/PDMR Shareholding
8th Jun 200910:48 amRNSHolding(s) in Company
8th Jun 20097:00 amRNSInterim Results 2009
27th May 20097:00 amRNSInterim Results Analyst Briefing
7th Apr 20097:00 amRNSNotice of Results & Pre-Close Trading Statement
4th Feb 20097:00 amRNSAGM Statement
8th Dec 20087:00 amRNSPreliminary Results
26th Nov 20087:00 amRNSNotice of Results
10th Nov 20087:00 amRNSNEW BIOGAS DIVISION
6th Oct 200812:02 pmRNSHolding(s) in Company
6th Oct 20087:00 amRNSPre-Close Trading Update
8th Sep 20087:00 amRNSOVERSEAS NAVAL CONTRACT WIN
5th Sep 20082:14 pmRNSDirector/PDMR Shareholding
4th Sep 20082:36 pmRNSDirector/PDMR Shareholding
20th Aug 20082:07 pmRNSDirector/PDMR Shareholding
18th Aug 20088:50 amRNSDirector/PDMR Shareholding
11th Aug 200812:50 pmRNSHolding(s) in Company
7th Aug 200810:21 amRNSHolding(s) in Company
1st Jul 20083:17 pmRNSDirector/PDMR Shareholding
30th Jun 20087:00 amRNSInterim Results
30th May 20084:02 pmRNSDirectorate Change
22nd Apr 20087:00 amRNSDirector/PDMR Shareholding
16th Apr 200811:19 amRNSHolding(s) in Company
14th Apr 20082:05 pmRNSDirectorate Change
14th Apr 20082:00 pmRNSDirectorate Change
9th Apr 200810:00 amRNSAGM Statement
17th Mar 20084:21 pmRNSAnnual Report and Accounts
11th Mar 200812:04 pmRNSHolding(s) in Company
12th Feb 20082:13 pmRNSDirector/PDMR Shareholding
12th Feb 200811:09 amRNSHolding(s) in Company
11th Feb 20085:14 pmRNSHolding(s) in Company
11th Feb 20085:13 pmRNSHolding(s) in Company
11th Feb 20085:12 pmRNSHolding(s) in Company
11th Feb 20085:10 pmRNSHolding(s) in Company
11th Feb 20085:08 pmRNSHolding(s) in Company
8th Feb 20087:00 amRNSDirector/PDMR Shareholding
4th Feb 20084:43 pmRNSDirector/PDMR S/hldg-Amend
4th Feb 20081:07 pmRNSDirector/PDMR Shareholding
30th Jan 20087:01 amRNSFinal Results
31st Dec 20079:14 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.